Global acceptance of biosimilars: importance of regulatory consistency, education, and trust

E Cazap, I Jacobs, A McBride, R Popovian… - The …, 2018 - academic.oup.com
… or summaries of product characteristics (SmPCs). In Europe, … systematic review of assessment
reports for biosimilars … and that, even for biosimilars referencing the same originator, there …

[引用][C] Biosimilar's Growth in Pharmerging Markets: An Analysis of the Regulatory Environments

R Batel - 2020 - University of the Western Cape

[DOC][DOC] Literature Review of International Biosimilar Medicines: Update December 2017–February 2018

M Ward, SR Lange, K Staff, P MPharm - health.gov.au
… during the review period that are of a technical nature and relate to topics such as the
physicochemical and pharmacological characterisation of potential biosimilar medicines. …

A bibliometric analysis of the global research on biosimilars

A Hernández-Vásquez, CA Alarcon-Ruiz… - … policy and practice, 2018 - Taylor & Francis
Biosimilars could be a promising option to help decrease healthcare costs and … analysis
on biosimilars. Therefore, we aimed to assess the quantity and quality of worldwide biosimilars

[PDF][PDF] Biosimilars in Dermatology: A Promising Solution to The High Cost of Biologic Therapy.(2023)

RS Hussein, SB Dayel - Int. J. Life Sci. Pharma Res - researchgate.net
… trials, systematic reviews, and observational studies that evaluated the use of biosimilars
in … and critical analysis of the current evidence on biosimilars in dermatology. This …

Neutropenic enterocolitis and sepsis: towards the definition of a pathologic profile

G Bertozzi, A Maiese, G Passaro, A Tosoni, A Mirijello… - Medicina, 2021 - mdpi.com
… After this literature review process, 19 papers were selected (Figure 2). … per the literature
review, is more frequently associated with a worse prognostic characterized by hemodynamic …

Indian biosimilars and vaccines at crossroads–replicating the success of pharmagenerics

S Panda, PK Singh, S Mishra, S Mitra, P Pattnaik… - Vaccines, 2023 - mdpi.com
biosimilars have been and are being tested to treat and manage COVID-19 symptoms
characterized … Results: This review assesses India’s situation in the biosimilar space, the gaps and …

[PDF][PDF] Comparative Cost Efficiency of the Originator Drug of Infliximab and its Biosimilar for the Treatment of Rheumatoid Arthritis in the MENA Region.

A Almaaytah, FD Elhajji - International Journal of Pharmaceutical …, 2019 - researchgate.net
… due to biosimilar use, this data is consistent with most biosimilar … impact analysis study for
infliximab and the same biosimilar (… antirheumatic drugs only: Systematic review and economic …

The Efficacy and Safety of Biosimilars in Hidradenitis Suppurativa: A Comprehensive Review

E Almukhadeb, A Almudimeegh… - Clinical, Cosmetic …, 2024 - Taylor & Francis
… ) has approved nine biosimilar medications for treating plaque … This review aims to enhance
understanding, provide … of biosimilars in HS management through a thorough analysis of …

[PDF][PDF] Reflections and perspectives on biosimilars in Brazil

RL Araujo, GBG Mosegui, C Vianna… - … of Pharmacy and …, 2020 - pdfs.semanticscholar.org
… was to map the characteristics and prices of biological and biosimilar medicines marketed in
… The concept of biosimilars: from characterization to evolution-a narrative review. Oncologist, …